Viral Conjunctivitis - Pipeline Review, H2 2014 Released On 7th September 2015
Summary ‘Viral Conjunctivitis Pipeline Review, H2 2014’, provides an overview of the Viral Conjunctivitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Viral Conjunctivitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Viral Conjunctivitis and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Viral Conjunctivitis - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Viral Conjunctivitis and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Viral Conjunctivitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Viral Conjunctivitis pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Viral Conjunctivitis - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Viral Conjunctivitis pipeline depth and focus of Indication therapeutics
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Browse complete Report on: http://www.jsbmarketresearch.com/healthcare-medical/r-viralconjunctivitis-pipeline-review-114110
Table of Contents List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Viral Conjunctivitis Overview 6 Therapeutics Development 7 Pipeline Products for Viral Conjunctivitis - Overview 7 Pipeline Products for Viral Conjunctivitis - Comparative Analysis 8 Viral Conjunctivitis - Therapeutics under Development by Companies 9 Viral Conjunctivitis - Pipeline Products Glance 10 Clinical Stage Products 10 Early Stage Products 11 Viral Conjunctivitis - Products under Development by Companies 12 Viral Conjunctivitis - Companies Involved in Therapeutics Development 13 Foresight Biotherapeutics, Inc. 13 NanoViricides, Inc. 14 NovaBay Pharmaceuticals, Inc. 15 Panoptes Pharma Ges.m.b.H. 16 Starpharma Holdings Limited 17 Viral Conjunctivitis - Therapeutics Assessment 18 Assessment by Monotherapy Products 18 Assessment by Target 19 JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Assessment by Mechanism of Action 21 Assessment by Route of Administration 23 Assessment by Molecule Type 25 Drug Profiles 26 astodrimer - Drug Profile 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 EKCCide-I - Drug Profile 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 FST-100 - Drug Profile 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 NVC-638 - Drug Profile 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 NVC-704 - Drug Profile 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 NVC-727 - Drug Profile 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 PP-001 - Drug Profile 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 Viral Conjunctivitis - Recent Pipeline Updates 35 Viral Conjunctivitis - Dormant Projects 38 Viral Conjunctivitis - Discontinued Products 39 Viral Conjunctivitis - Product Development Milestones 40 Featured News & Press Releases 40 JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
May 13, 2013: Starpharmas Dendrimer SPL7013 Demonstrates Potential As Viral Conjunctivitis Treatment 40 May 05, 2010: Foresight Biotherapeutics, Inc s Drug FST-100 Reduces Infectious Adenoviral Titers And Improves Clinical Signs in Conjunctivitis Model 40 Appendix 42 Methodology 42 Coverage 42 Secondary Research 42 Primary Research 42 Expert Panel Validation 42 Contact Us 43 Disclaimer 43 List Of Tables Number of Products under Development for Viral Conjunctivitis, H2 2014 7 Number of Products under Development for Viral Conjunctivitis - Comparative Analysis, H2 2014 8 Number of Products under Development by Companies, H2 2014 9 Comparative Analysis by Clinical Stage Development, H2 2014 10 Comparative Analysis by Early Stage Development, H2 2014 11 Products under Development by Companies, H2 2014 12 Viral Conjunctivitis - Pipeline by Foresight Biotherapeutics, Inc., H2 2014 13 Viral Conjunctivitis - Pipeline by NanoViricides, Inc., H2 2014 14 Viral Conjunctivitis - Pipeline by NovaBay Pharmaceuticals, Inc., H2 2014 15 Viral Conjunctivitis - Pipeline by Panoptes Pharma Ges.m.b.H., H2 2014 16 Viral Conjunctivitis - Pipeline by Starpharma Holdings Limited, H2 2014 17 Assessment by Monotherapy Products, H2 2014 18 Number of Products by Stage and Target, H2 2014 20 Number of Products by Stage and Mechanism of Action, H2 2014 22 Number of Products by Stage and Route of Administration, H2 2014 24 Number of Products by Stage and Molecule Type, H2 2014 25 Viral Conjunctivitis Therapeutics - Recent Pipeline Updates, H2 2014 35 Viral Conjunctivitis - Dormant Projects, H2 2014 38 Viral Conjunctivitis - Discontinued Products, H2 2014 39 List Of Figures JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Number of Products under Development for Viral Conjunctivitis, H2 2014 7 Number of Products under Development for Viral Conjunctivitis - Comparative Analysis, H2 2014 8 Number of Products under Development by Companies, H2 2014 9 Assessment by Monotherapy Products, H2 2014 18 Number of Products by Top 10 Targets, H2 2014 19 Number of Products by Stage and Top 10 Targets, H2 2014 20 Number of Products by Top 10 Mechanism of Actions, H2 2014 21 Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 22 Number of Products by Top 10 Routes of Administration, H2 2014 23 Number of Products by Stage and Top 10 Routes of Administration, H2 2014 24 Number of Products by Stage and Top 10 Molecule Types, H2 2014 25 Product Price :
License Type
Price
$ 2000
Site Licence
$ 4000
Enterprise Wide Licence
$ 6000
Related reports: Autism - Pipeline Review, H1 2015 Gouty Arthritis (Gout) - Pipeline Review, H1 2015 Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015 JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Mild Cognitive Impairment - Pipeline Review, H1 2015 Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) - Pipeline Review, H1 2015 Osteoporosis - Pipeline Review, H1 2015 Healthcare and Medical Market Research About JSB Market Research:JSB market research is amongst the best online market research companies providing the most significant online database of various industry research reports and services. This online portal contains high-quality market research reports with well-researched content on a wide range of industries. We specialize in providing the best market research reports for various industries. To know more on “Viral Conjunctivitis - Pipeline Review, H2 2014� http://www.jsbmarketresearch.com/healthcare-medical/r-viral-conjunctivitispipeline-review-114110
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/